Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 930.82 $ 23.63 (2.6 %)    

Wednesday, 14-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.74 $ 0.15 (0.03 %)
DIA $ 400.12 $ 2.30 (0.58 %)
SPY $ 543.85 $ 1.71 (0.32 %)
TLT $ 97.88 $ 0.61 (0.63 %)
GLD $ 226.19 $ -1.86 (-0.82 %)
$ 931.68
$ 930.60 x 100
-- x --
-- - --
$ 513.84 - $ 966.10
3,562,910
na
842.43B
$ 0.60
$ 114.74
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-17-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-19-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 07-25-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-29-2016 03-31-2016 10-Q
35 02-19-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-19-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dont-promote-copycat-weight-loss-drugs-amid-improved-supply-eli-lilly-asks-doctors-fda-evaluates
Don't Promote Copycat Weight-Loss Drugs Am...
08/14/2024 18:35:14

Eli Lilly issues cease-and-desist letters to healthcare providers, demanding they stop promoting compounded weight-loss drugs a...

berenberg-maintains-buy-on-eli-lilly-raises-price-target-to-1050
Berenberg Maintains Buy on Eli Lilly, Rais...
08/14/2024 16:53:02

Berenberg analyst Kerry Holford maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1000 to $1050.

lilly-demands-doctors-stop-selling-copycat-weight-loss-drugs-supply-of-mounjaro-zepbound-growing-but-us-shortage-exists-drugmaker-sent-cease-and-desist-letters-to-various-providers---bloomberg-news
'Lilly Demands Doctors Stop Selling Copyca...
08/14/2024 15:09:03

https://www.bloomberg.com/news/articles/2024-08-14/lilly-lly-demands-doctors-stop-selling-copycat-weight-loss-drugsEli Lilly &a...

eli-lilly-smashed-estimates-thanks-to-unbelievable-demand-for-its-diabetes-and-weight-loss-blockbusters
Eli Lilly Smashed Estimates Thanks To Unbe...
08/14/2024 14:26:17

On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity...

heres-how-much-you-would-have-made-owning-eli-lilly-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
08/13/2024 18:00:34

voo-vs-vti-here-are-the-key-differences-between-vanguard-us-stock-market-etfs-investors-should-know
VOO Vs. VTI: Here Are The Key Differences ...
08/13/2024 12:45:56

A look at the differences and past performance of the VOO and VTI ETFs and how they compare to the SPY ETF.

weight-loss-drugs-like-ozempic-zepbound-may-reduce-cancer-risks-studies-suggest
Weight Loss Drugs Like Ozempic, Zepbound M...
08/12/2024 17:37:30

GLP-1 agonists like Ozempic and Wegovy, known for treating obesity and diabetes, are now showing potential in reducing cancer r...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

eli-lilly-to-rally-around-15-here-are-10-top-analyst-forecasts-for-monday
Eli Lilly To Rally Around 15%? Here Are 10...
08/12/2024 13:46:00

this-robinhood-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Robinhood Analyst Turns Bullish; Here...
08/12/2024 13:11:46

Core News & Articles
Market-Moving News for August 12th
08/12/2024 12:21:29

KEY: 24% | Scotiabank Acquires 14.9% Stake in KeyCorp With $2.8B Strategic Investment ASND: 11% | Ascendia Pharma shares are tr...

eli-lilly-shares-are-trading-higher-after-deutsche-bank-upgraded-the-stock-from-hold-to-buy-and-raised-its-price-target-from-725-to-1025
Eli Lilly shares are trading higher after ...
08/12/2024 12:12:26

beyond-the-numbers-25-analysts-discuss-eli-lilly-stock
Beyond The Numbers: 25 Analysts Discuss El...
08/12/2024 12:00:17

deutsche-bank-upgrades-eli-lilly-to-buy-raises-price-target-to-1025
Deutsche Bank Upgrades Eli Lilly to Buy, R...
08/12/2024 11:59:25

Deutsche Bank analyst James Shin upgrades Eli Lilly (NYSE:LLY) from Hold to Buy and raises the price target from $725 to $1025.

sp-500-erases-weekly-losses-nasdaq-100-ends-4-week-slide-as-bulls-regain-momentum-fridays-stock-movers-at-the-close
S&P 500 Erases Weekly Losses, Nasdaq 100 E...
08/09/2024 20:13:55

Market indexes rose on Friday, wiping out weekly losses and easing economic fears. Positive catalysts calmed volatility and rea...

eli-lillys-q2-sales-surge-36-analysts-cautious-on-future-supply-market-dynamics-optimistic-about-next-gen-oral-weight-loss-drug
Eli Lilly's Q2 Sales Surge 36%, Analysts C...
08/09/2024 20:03:04

Eli Lilly's Q2 revenue soared to $11.3 billion, surpassing forecasts. Mounjaro sales tripled and Zepbound revenue grew sign...

wall-street-momentum-stalls-after-thursdays-rally-palantir-jumps-to-3-year-highs-bonds-rally-whats-driving-markets-friday
Wall Street Momentum Stalls After Thursday...
08/09/2024 17:13:36

After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s ...

expedia-posts-upbeat-earnings-joins-akamai-technologies-trade-desk-dxc-technology-and-other-big-stocks-moving-higher-on-friday
Expedia Posts Upbeat Earnings, Joins Akama...
08/09/2024 16:51:33

wells-fargo-maintains-overweight-on-eli-lilly-raises-price-target-to-1000
Wells Fargo Maintains Overweight on Eli Li...
08/09/2024 15:55:22

Wells Fargo analyst Mohit Bansal maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $875 to $...

analyzing-eli-lilly-in-comparison-to-competitors-in-pharmaceuticals-industry
Analyzing Eli Lilly In Comparison To Compe...
08/09/2024 15:00:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION